GLP-1/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet

Diabetes

Volumn 63, Issue 4, 2014, Pages 1422-1427

  Clemmensen, Christoffer ^a   Chabenne, Joseph ^b   Finan, Brian ^a   Sullivan, Lorraine ^b   Fischer, Katrin ^a   Küchler, Daniela ^a   Sehrer, Laura ^a   Ograjsek, Teja ^c   Hofmann, Susanna M ^c   Schriever, Sonja C ^a   Pfluger, Paul T ^a   Pinkstaff, Jason ^b   Tschöp, Matthias H ^a   DiMarchi, Richard ^d   Müller, Timo D ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b AMBRX INC   (United States)

^c UNIVERSITY OF MUNICH   (Germany)

^d INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON RECEPTOR; LEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET; DIET INDUCED OBESITY; DRUG POTENTIATION; FAT INTAKE; FOOD INTAKE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HORMONAL THERAPY; IN VIVO STUDY; LIPID DIET; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SUPPLEMENTATION; WEIGHT REDUCTION;

ANIMALS; DIET, HIGH-FAT; EATING; FOOD HABITS; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; POLYETHYLENE GLYCOLS; RECEPTORS, GLUCAGON; WEIGHT LOSS;

EID: 84897909191     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1609     Document Type: Article

References (23)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432
2. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A 1997;94:8878-8883
3. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-546
4. Licinio J, Caglayan S, Ozata M, et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A 2004;101:4531-4536
5. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002;110:1093-1103
6. Heymsfield SB, Greenberg AS, Fujioka K, et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999;282:1568-1575
7. Scarpace PJ, Zhang Y. Leptin resistance: a prediposing factor for diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2009;296:R493-R500
8. Hukshorn CJ, Saris WH, Westerterp-Plantenga MS, Farid AR, Smith FJ, Campfield LA. Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men. J Clin Endocrinol Metab 2000;85:4003-4009
9. Roth JD, Roland BL, Cole RL, et al. Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc Natl Acad Sci U S A 2008;105:7257-7262
10. Müller TD, Sullivan LM, Habegger K, et al. Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21. J Pept Sci 2012;18: 383-393
11. Trevaskis JL, Lei C, Koda JE, Weyer C, Parkes DG, Roth JD. Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats. Obesity (Silver Spring) 2010;18:21-26
12. Sadry SA, Drucker DJ. Emerging combinatorial hormone therapies for the treatment of obesity and T2DM. Nat Rev Endocrinol 2013;9:425-433
13. Coppari R, Bjørbæk C. Leptin revisited: its mechanism of action and potential for treating diabetes. Nat Rev Drug Discov 2012;11:692-708
14. Vasselli JR, Scarpace PJ, Harris RB, Banks WA. Dietary components in the development of leptin resistance. Adv Nutr 2013;4:164-175
15. Vasselli JR. The role of dietary components in leptin resistance. Adv Nutr 2012;3:736-738
16. Vasselli JR. Fructose-induced leptin resistance: discovery of an unsuspected form of the phenomenon and its significance. Focus on " Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding," by Shapiro et al. Am J Physiol Regul Integr Comp Physiol 2008;295:R1365-R1369
17. Vasselli JR. Behavioral and biological determinants of leptin resistance. Appetite 2001;37:115-117
18. Thaler JP, Yi CX, Schur EA, et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest 2012;122:153-162
19. Wang J, Obici S, Morgan K, Barzilai N, Feng Z, Rossetti L. Overfeeding rapidly induces leptin and insulin resistance. Diabetes 2001;50:2786-2791
20. Day JW, Ottaway N, Patterson JT, et al. A new glucagon and GLP-1 coagonist eliminates obesity in rodents. Nat Chem Biol 2009;5:749-757
21. Beiroa D, Romero-Picó A, Langa C, et al. Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet. PLoS ONE 2013;8:e54591
22. Banks WA, Coon AB, Robinson SM, et al. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 2004;53:1253-1260
23. Shapiro A, Mu W, Roncal C, Cheng KY, Johnson RJ, Scarpace PJ. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol Regul Integr Comp Physiol 2008;295:R1370-R1375